Andrew Cameron - Concepedia

Author

Andrew Cameron

Also Known As

A Cameron, A. Cameron, A.M. >Cameron, A.M. Cameron, Aliya M. Cameron, Andrew M. Cameron, Andrew Cameron, Andrew M Cameron, Andrew M. Cameron, Andrew MacGregor Cameron

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine University of California, Los Angeles Biogen (United States)Sidney Kimmel Cancer Center

About

Andrew Cameron is an author at Johns Hopkins University specializing in medicine, hepatology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	873
2	Health Sciences	2	2	250
3	Natural Sciences	2	2	90
4	Education	1	1	23
5	African American Studies	1	1	23

Andrew Cameron

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Current Surgical Therapy Andrew Cameron Annals of Surgery Transplantation SurgerySurgical OncologyRutland AveAndrew M. CameronSurgical Science	2017	307
Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity Ling Li, Hildur Knútsdóttir, Ken Hui, JCI Insight HepatologyHepatocellular CarcinomaTumor HeterogeneityLiver PhysiologyDrug Response Heterogeneity	2019	201
BIN1 favors the spreading of Tau via extracellular vesicles Andrea Crotti, Hameetha Rajamohamend Sait, Kathleen M. McAvoy, Scientific Reports	2019	161
Factors Affecting Graft Survival After Adult/Child Split-Liver Transplantation: Analysis of the UNOS/OPTN Data Base K.W. Lee, Andrew Cameron, Warren R. Maley, American Journal of Transplantation	2008	80
Characterization of tau binding by gosuranemab Richelle Sopko, Olga Golonzhka, Joseph W. Arndt, Neurobiology of Disease Protein AssemblyImmunologyMolecular BiologyImmunotherapyChemical Biology	2020	59
Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench Walter Rodríguez, Banrida Wahlang, Yali Wang, Hepatology Phosphodiesterase 4ImmunologyFatty Liver DiseaseOxidative StressInflammation	2019	58
Ischemic cholangiopathy after liver transplantation. Andrew Cameron, Ronald W. Busuttil PubMed	2005	52
Fulminant Hepatic Failure from Primary Hepatic Lymphoma: Successful Treatment with Orthotopic Liver Transplantation and Chemotherapy Andrew Cameron, Jadwiga Truty, Jeff S. Truell, Transplantation ImmunologyOrthotopic Liver TransplantationPathologyCirrhosisHepatobiliary Tumor	2005	49
Prevalence of Anti‐HCV Antibodies Confirmed by Recombinant Immunoblot in Different Population Subsets in The Netherlands C.L. van der Poel, H. W. Reesink, E. P. Mauser‐Bunschoten, Vox Sanguinis	1991	42
Mobilization of Host Stem Cells Enables Long-Term Liver Transplant Acceptance in a Strongly Rejecting Rat Strain Combination Takehiro Okabayashi, Andrew Cameron, Masayuki Hisada, American Journal of Transplantation	2011	38

Page 1